510(k) Report

FDA applicant

Q'Apel Medical, Inc.

Fremont, CA7 decisions2019–20261 recall

FDA records 7 decisions for Q'Apel Medical, Inc. (Fremont, CA) from 2019 to 2026: 7 510(k) clearances. Most are in product codes QJP (Catheter, Percutaneous, Neurovasculature) and NRY (Catheter, Thrombus Retriever). Since 2016 its 510(k)s took a median of 128 days from receipt to decision, against 139 for FDA’s reviews in the same codes and years. Its devices cite 10 predicates, 2 of them its own earlier devices. 1 recall is linked to its devices, 1 Class I.

FDA’s records also spell it “Q'Apel Medical, LLC”, “Q'Apel Medical”, “Q’Apel Medical, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Q'Apel Medical, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2024

2019: 22021: 12023: 22024: 12026 (partial year): 1
2019high 2 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

1in 2025

2025: 1, 1 Class I
2019high 1 (2025) · low 0 (2019)2026

Class I Class II/III not classified

FIG. 1 — Q'Apel Medical, Inc. by year, 2019–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Q'Apel Medical, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report